Serum Institute of India, the world’s largest vaccine producer, sees AstraZeneca Plc’s COVID-19 vaccine candidate as a “very good” option, giving it a major vote of confidence after some experts raised questions around its trial data. Serum Institute of India (SII), which has partnered with the British drugmaker to conduct trials on its COVISHIELD vaccine in India and produce the vaccine candidate if it secures approval, plans to apply for an emergency use licence for the vaccine in the next two weeks, said SII’s Chief Executive Adar Poonawalla. “This vaccine is a very good one,” said Poonawalla, via a virtual press briefing following Indian Prime Minister Narendra Modi’s visit to SII’s campus on Saturday. […] “Both our vaccine candidates can be stored in 2 Celsius to 8 Celsius and India has lot of storage and infrastructure for that temperature range. It has slightly less storage capacity for -20 C and almost nothing for -70 C,” said Poonawalla. […] Moderna has said its vaccine can be stored at normal fridge temperatures of 2 to 8 degrees Celsius for 30 days and it can be stored for up to 6 months at -20C.
Click here to read the full article